Home/Qeen Biotechnologies/Dr. Nancy Tawil
DN

Dr. Nancy Tawil

CEO

Qeen Biotechnologies

Qeen Biotechnologies Pipeline

DrugIndicationPhase
QPH-ECEscherichia coli infections (human & animal)Preclinical
QPH-SAStaphylococcus aureus infections (human & veterinary)Preclinical
QPH-PAPseudomonas aeruginosa infections (human & cystic fibrosis)Preclinical
QPH-VCVibrio spp. infections in aquaculturePreclinical